White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment
- PMID: 23375566
- PMCID: PMC3663926
- DOI: 10.1016/j.jalz.2012.11.009
White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment
Abstract
Background: Current hypothetical models of Alzheimer's disease (AD) pathogenesis emphasize the role of β-amyloid (Aβ), tau deposition, and neurodegenerative changes in the mesial temporal lobe, particularly the entorhinal cortex and hippocampus. However, many individuals with clinical AD who come to autopsy also exhibit cerebrovascular disease. The relationship between AD and vascular pathology is unclear, especially whether they represent additive and independent effects on neuronal injury. We used data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) to (1) confirm whether entorhinal cortex and hippocampal volume are associated with memory among individuals with amnestic mild cognitive impairment (MCI) who are at risk for AD; and (2) determine whether regional white matter hyperintensity (WMH) volume, a radiological marker of small-vessel cerebrovascular disease, is associated with entorhinal cortex and hippocampal volume independent of putative AD biomarkers in this group.
Methods: Cognitive test scores, entorhinal cortex volume, hippocampus volume, intracranial volume, and cerebrospinal fluid-derived phosphorylated tau and Aβ1-42 protein levels were measured in 199 subjects with amnestic MCI (mean age = 74.89 ± 7.47). Lobar WMH volumes were derived from T1-, proton-density-, and T2-weighted magnetic resonance imaging scans. We examined the association between entorhinal cortex volume and cognition. Next, we examined the association of tau and Aβ1-42 with entorhinal cortex volume and between lobar WMH and entorhinal cortex volume. Finally, tau, Aβ1-42, and regional WMH volumes were entered simultaneously to predict entorhinal cortex volume. We repeated the analyses with hippocampal volume instead of entorhinal cortex volume. The analyses were also repeated with the sample restricted to those MCI patients who transitioned to AD on subsequent ADNI follow-up visits (n = 86).
Results: Larger entorhinal cortex volume was associated with better memory but not with performance on a task of executive functioning. Lower levels of Aβ1-42 and higher temporal WMH volumes were associated with smaller entorhinal cortex volume. When entered simultaneously, temporal lobe WMH volume was more reliably associated with entorhinal cortex volume than was Aβ1-42. The findings were similar for hippocampus volume and when the sample was restricted to MCI patients who subsequently transitioned to AD.
Conclusions: The findings confirm the role of entorhinal cortex and hippocampus volume in influencing memory decline in amnestic MCI, and emphasize that even in this nominally AD prodromal condition, WMH may be influencing regional neurodegeneration.
Keywords: Alzheimer's disease; Mild cognitive impairment; Tau; White matter hyperintensities; β-amyloid.
Copyright © 2013 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment.Alzheimers Dement. 2015 Dec;11(12):1510-1519. doi: 10.1016/j.jalz.2015.05.014. Epub 2015 Jun 13. Alzheimers Dement. 2015. PMID: 26079417 Free PMC article.
-
Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.J Alzheimers Dis. 2023;92(1):323-339. doi: 10.3233/JAD-220846. J Alzheimers Dis. 2023. PMID: 36744337 Free PMC article.
-
Associations of tau, Aβ, and brain volume of the Papez circuit with cognition in Alzheimer's disease.Eur Arch Psychiatry Clin Neurosci. 2025 Feb;275(1):241-256. doi: 10.1007/s00406-024-01827-7. Epub 2024 Jun 2. Eur Arch Psychiatry Clin Neurosci. 2025. PMID: 38824476
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S89-S97. doi: 10.1002/alz.13402. Epub 2023 Jul 25. Alzheimers Dement. 2023. PMID: 37491599 Free PMC article. Review.
Cited by
-
Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease.J Prev Alzheimers Dis. 2021;8(3):240-248. doi: 10.14283/jpad.2021.14. J Prev Alzheimers Dis. 2021. PMID: 34101779 Free PMC article. Clinical Trial.
-
Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.Aging (Albany NY). 2021 Apr 16;13(8):10973-10988. doi: 10.18632/aging.202977. Epub 2021 Apr 16. Aging (Albany NY). 2021. PMID: 33861727 Free PMC article.
-
Pattern of regional white matter hyperintensity volume in mild cognitive impairment subtypes and associations with decline in daily functioning.Neurobiol Aging. 2020 Feb;86:134-142. doi: 10.1016/j.neurobiolaging.2019.10.016. Epub 2019 Nov 2. Neurobiol Aging. 2020. PMID: 31791658 Free PMC article.
-
Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging.Ann Neurol. 2018 Nov;84(5):705-716. doi: 10.1002/ana.25346. Epub 2018 Oct 25. Ann Neurol. 2018. PMID: 30264411 Free PMC article.
-
Periventricular hyperintensities are associated with elevated cerebral amyloid.Neurology. 2016 Feb 9;86(6):535-43. doi: 10.1212/WNL.0000000000002352. Epub 2016 Jan 8. Neurology. 2016. PMID: 26747881 Free PMC article.
References
-
- Tapiola TAIHS, et al. CErebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of alzheimer-type pathologic changes in the brain. Archives of neurology. 2009;66(3):382–389. - PubMed
-
- Jagust W, Reed B, Mungas D, Ellis W, Decarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology. 2007 Aug 28;69(9):871–877. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical